| Financial Year |
March 31 2023 |
| Monetary Funds |
68,225,646.02 |
| Held-for-trading Financial Assets |
535,768,474.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
62,026,262.24 |
| Advances to Suppliers |
194,189,747.51 |
| Other Receivables |
31,853,468.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
780,190,431.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,131,420.91 |
| Other Current Assets |
94,546,786.60 |
| Total Current Assets |
1,776,932,237.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
59,833,550.59 |
| Long-term Equity Investment |
21,134,232.59 |
| Investment Properties |
-- |
| Fixed Assetes |
134,284,531.44 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,057,943.14 |
| R&D expenses |
-- |
| Goodwill |
135,763,688.47 |
| Long-Term Deferred and Prepaid Expenses |
31,244,967.16 |
| Deferred Income Tax Assets |
46,719,352.61 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
985,470,084.98 |
| Total Assets |
2,762,402,322.60 |
| Short-Term Loans |
424,154,416.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
455,665,455.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
74,766,690.00 |
| Taxes Payable |
21,902,508.68 |
| Interest Payable |
35,583.34 |
| Dividend Payable |
-- |
| Other payables |
37,674,392.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
201,652,822.40 |
| Other Current Liabilities |
52,179,755.93 |
| Sub-Total of Current Liabilities |
1,365,471,425.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,110,776.21 |
| Deferred Income Tax Liabilities |
28,152,723.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
274,408,353.27 |
| Total Liabilities |
1,639,879,778.35 |
| Paid-In Capital(Or Share Stock) |
140,516,936.00 |
| Capital Surplus |
314,286,177.63 |
| Surplus Reserve |
40,085,607.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
581,879,013.72 |
| Minority Stockholder's Interest |
43,161,725.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,079,360,818.47 |
| Owner's Equity（Stockholder's Equity） |
1,122,522,544.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,762,402,322.60 |
